Quantitative proteomics of changes in energy metabolism-related proteins in atrial tissue from valvular disease patients with permanent atrial fibrillation
- PMID: 24553264
- DOI: 10.1253/circj.cj-13-1365
Quantitative proteomics of changes in energy metabolism-related proteins in atrial tissue from valvular disease patients with permanent atrial fibrillation
Abstract
Background: The modification of cardiac energy metabolism during atrial fibrillation (AF) has been demonstrated in previous studies, indicating a close association between these 2 processes. The aim of the present study was to identify the underlying mechanisms via profiling of the expression of energy metabolism-related proteins in the left atrial appendage (LAA) of patients with AF.
Methods and results: Isobaric tag for relative and absolute quantification-coupled 2-D liquid chromatography-tandem mass spectrometry (iTRAQ-coupled 2-D LC-MS/MS) was used to profile the expression of energy metabolism-related proteins in the LAA from valvular disease patients with sinus rhythm (SR; n=6) and AF (n=8). Using ProteinPilot 4.0, 122 energy metabolism-related proteins, consisting of 39 carbohydrate metabolism-related proteins, 22 proteins involved in lipid metabolism, 49 biological oxidation-related proteins and 12 other kinds of proteins, were identified. Most of them were key enzymes involved in energy metabolism. Moreover, most of the proteins that were expressed differently in the LAA between the AF and SR patients, and which were related to energy metabolism, were downregulated. These results were further validated on western blot.
Conclusions: Atrial myocardium energy production in valvular disease patients is impaired during permanent AF, and this impairment in energy production may be involved in the matrix of AF formation.
Similar articles
-
Quantitative acetylated proteomics on left atrial appendage tissues revealed atrial energy metabolism and contraction status in patients with valvular heart disease with atrial fibrillation.Front Cardiovasc Med. 2022 Sep 13;9:962036. doi: 10.3389/fcvm.2022.962036. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36176981 Free PMC article.
-
Disturbed Cardiac Metabolism Triggers Atrial Arrhythmogenesis in Diabetes Mellitus: Energy Substrate Alternate as a Potential Therapeutic Intervention.Cells. 2022 Sep 18;11(18):2915. doi: 10.3390/cells11182915. Cells. 2022. PMID: 36139490 Free PMC article. Review.
-
Quantitative proteomics of changes in succinylated proteins expression profiling in left appendages tissue from valvular heart disease patients with atrial fibrillation.Clin Chim Acta. 2019 Aug;495:345-354. doi: 10.1016/j.cca.2019.05.002. Epub 2019 May 3. Clin Chim Acta. 2019. PMID: 31059701
-
Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.Int J Cardiol. 2013 Oct 3;168(3):2177-85. doi: 10.1016/j.ijcard.2013.01.239. Epub 2013 Mar 7. Int J Cardiol. 2013. PMID: 23465222
-
The Role of Mitochondrial Dysfunction in Atrial Fibrillation: Translation to Druggable Target and Biomarker Discovery.Int J Mol Sci. 2021 Aug 6;22(16):8463. doi: 10.3390/ijms22168463. Int J Mol Sci. 2021. PMID: 34445167 Free PMC article. Review.
Cited by
-
Amino acid profile alteration in age-related atrial fibrillation.J Transl Med. 2024 Mar 9;22(1):259. doi: 10.1186/s12967-024-05028-7. J Transl Med. 2024. PMID: 38461346 Free PMC article.
-
Advanced Glycation End Products Downregulate Connexin 43 and Connexin 40 in Diabetic Atrial Myocytes via the AMPK Pathway.Diabetes Metab Syndr Obes. 2023 Oct 2;16:3045-3056. doi: 10.2147/DMSO.S419189. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37810573 Free PMC article.
-
Long Non-coding RNA Involved in the Pathophysiology of Atrial Fibrillation.Cardiovasc Drugs Ther. 2023 Sep 13. doi: 10.1007/s10557-023-07491-8. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37702834 Review.
-
Quantitative acetylated proteomics on left atrial appendage tissues revealed atrial energy metabolism and contraction status in patients with valvular heart disease with atrial fibrillation.Front Cardiovasc Med. 2022 Sep 13;9:962036. doi: 10.3389/fcvm.2022.962036. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36176981 Free PMC article.
-
Disturbed Cardiac Metabolism Triggers Atrial Arrhythmogenesis in Diabetes Mellitus: Energy Substrate Alternate as a Potential Therapeutic Intervention.Cells. 2022 Sep 18;11(18):2915. doi: 10.3390/cells11182915. Cells. 2022. PMID: 36139490 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
